Literature DB >> 22102727

Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.

Dammanahalli K Jagadeesha1, Maysam Takapoo, Botond Banfi, Ramesh C Bhalla, Francis J Miller.   

Abstract

AIMS: In atherosclerosis and restenosis, vascular smooth muscle cells (SMCs) migrate into the subendothelial space and proliferate, contributing to neointimal formation. The goal of this study was to define the signalling pathway by which Nox1 NAPDH oxidase mediates SMC migration. METHODS AND
RESULTS: SMCs were cultured from thoracic aorta from Nox1(-/y) (Nox1 knockout, KO) and wild-type (WT) mice. In response to thrombin, WT but not Nox1 KO SMCs generated increased levels of reactive oxygen species (ROS). Deficiency of Nox1 prevented thrombin-induced phosphorylation of Src and the subsequent transactivation of the epidermal growth factor receptor (EGFR) at multiple tyrosine residues. Next, activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and matrix metalloproteinase-9 (MMP-9) by thrombin was inhibited by the EGFR inhibitor AG1478 and in Nox1 KO SMCs. Thrombin-induced shedding of N-cadherin from the plasma membrane was dependent on the presence of Nox1 and was blocked by AG1478 and an inhibitor of metalloproteinases. Migration of SMCs to thrombin was impaired in the Nox1 KO SMCs and was restored by expression of Nox1. Finally, treatment of WT SMCs with AG1478 abrogated Nox1-dependent SMC migration.
CONCLUSIONS: The Nox1 NADPH oxidase signals through EGFR to activate MMP-9 and promote the shedding of N-cadherin, thereby contributing to SMC migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102727      PMCID: PMC3282575          DOI: 10.1093/cvr/cvr308

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  40 in total

Review 1.  Regulation of tyrosine kinase cascades by G-protein-coupled receptors.

Authors:  L M Luttrell; Y Daaka; R J Lefkowitz
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

2.  Decreased blood pressure in NOX1-deficient mice.

Authors:  Gaetan Gavazzi; Botond Banfi; Christine Deffert; Laurence Fiette; Michela Schappi; Francois Herrmann; Karl-Heinz Krause
Journal:  FEBS Lett       Date:  2005-12-22       Impact factor: 4.124

3.  Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.

Authors:  S J George; J L Johnson; G D Angelini; A C Newby; A H Baker
Journal:  Hum Gene Ther       Date:  1998-04-10       Impact factor: 5.695

4.  Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo.

Authors:  R Forough; N Koyama; D Hasenstab; H Lea; M Clowes; S T Nikkari; A W Clowes
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

5.  Migratory abilities of different vascular cells from the tunica media of canine vessels.

Authors:  C L Seidel; T Helgason; J C Allen; C Wilson
Journal:  Am J Physiol       Date:  1997-03

6.  Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats.

Authors:  D K Jagadeesha; Timothy E Lindley; Jason Deleon; Ram V Sharma; Francis Miller; Ramesh C Bhalla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-15       Impact factor: 4.733

7.  Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.

Authors:  R Gallo; A Padurean; V Toschi; J Bichler; J T Fallon; J H Chesebro; V Fuster; J J Badimon
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

8.  Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.

Authors:  Gregory T Jones; I Patrick Kay; J W S Chu; G T Wilkins; L V Phillips; M McCormick; A M van Rij; M J A Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-11       Impact factor: 8.311

9.  Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury.

Authors:  C M Dollery; S E Humphries; A McClelland; D S Latchman; J R McEwan
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

10.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

Authors:  F J Miller; D D Gutterman; C D Rios; D D Heistad; B L Davidson
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

View more
  33 in total

1.  The NOX-ROS connection: targeting Nox1 control of N-cadherin shedding in vascular smooth muscle cells.

Authors:  Eileen M Redmond; Paul A Cahill
Journal:  Cardiovasc Res       Date:  2012-01-20       Impact factor: 10.787

Review 2.  Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.

Authors:  Aurelie Nguyen Dinh Cat; Augusto C Montezano; Dylan Burger; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

3.  Effect of a single, open-sea, air scuba dive on human micro- and macrovascular function.

Authors:  Kate Lambrechts; Jean-Michel Pontier; Costantino Balestra; Aleksandra Mazur; Qiong Wang; Peter Buzzacott; Michael Theron; Jacques Mansourati; François Guerrero
Journal:  Eur J Appl Physiol       Date:  2013-08-15       Impact factor: 3.078

4.  Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.

Authors:  Rohun U Palekar; Chandu Vemuri; Jon N Marsh; Batool Arif; Samuel A Wickline
Journal:  J Vasc Surg       Date:  2015-10-17       Impact factor: 4.268

5.  Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.

Authors:  T Bruder-Nascimento; P Chinnasamy; D F Riascos-Bernal; S B Cau; G E Callera; R M Touyz; R C Tostes; N E S Sibinga
Journal:  J Mol Cell Cardiol       Date:  2014-01       Impact factor: 5.000

6.  Redox Activation of Nox1 (NADPH Oxidase 1) Involves an Intermolecular Disulfide Bond Between Protein Disulfide Isomerase and p47phox in Vascular Smooth Muscle Cells.

Authors:  Marcela Gimenez; Sidney Veríssimo-Filho; Ilka Wittig; Brandon M Schickling; Fabian Hahner; Christoph Schürmann; Luis E S Netto; José César Rosa; Ralf P Brandes; Simone Sartoretto; Lívia De Lucca Camargo; Fernando Abdulkader; Francis J Miller; Lucia Rossetti Lopes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

7.  Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

Authors:  Anthony J Valente; Tadashi Yoshida; Subramanyam N Murthy; Siva S V P Sakamuri; Masato Katsuyama; Robert A Clark; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

8.  Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress.

Authors:  Shiny Abhijit; Regin Bhaskaran; Abirami Narayanasamy; Anand Chakroborty; Nagaraj Manickam; Madhulika Dixit; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2012-10-17       Impact factor: 3.396

9.  The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling.

Authors:  David E Heppner; Milena Hristova; Christopher M Dustin; Karamatullah Danyal; Aida Habibovic; Albert van der Vliet
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

10.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.